 |
市场调查报告书
商品编码
1529919
鼻腔给药市场：按容器形式、按应用、按最终用户、按地区Intranasal Drug Delivery Devices Market, By Dosage Form, By Application (Chronic Obstructive Pulmonary Disease, Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Others), By End User, By Geography |
||||||
预计2024年全球鼻腔给药装置市场规模为17亿美元，预计2031年将达32.7亿美元，2024年至2031年复合年增长率为9.8%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 17亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 2024-2031 年预测期复合年增长率 | 9.80% | 2031 年金额预测 | 32.7亿美元 |
全球鼻腔给药市场的成长是由鼻腔给药的相关优势所推动的，例如避免首过肝臟代谢、药物快速吸收进入体循环以及从鼻子直接进入大脑等。鼻腔给药允许透过非侵入性途径进行局部和全身给药。专注于开发先进鼻喷雾和雾化器技术的公司增加产品推出和进行大量投资可能会推动市场成长。
市场动态：
鼻腔给药装置的全球市场成长是由对替代给药途径的偏好、需要长期药物治疗的慢性病盛行率上升以及鼻腔给药装置的技术进步所推动的。鼻腔给药的非侵入性和快速起效鼓励各种药物开发商开拓此途径。然而，鼻吸收药物分子大小的限制以及鼻刺激和鼻塞风险等因素可能会阻碍市场成长。专注于增加适用药物分子的种类和製定更安全的鼻腔给药技术的持续研究和开发可以为市场成长提供利润丰厚的机会。
本研究的主要特点
该报告对全球鼻腔给药装置市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。发表。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球鼻给药设备市场的主要企业。
主要企业包括 OptiNose、默克、葛兰素史克、阿斯特捷利康、赛诺菲等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球鼻给药装置市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- 一致的机会地图 (COM)
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球鼻腔给药装置市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章 2019-2031 年全球经皮给药装置市场（按剂型）（十亿美元）
- 介绍
- 鼻喷剂
- 滴鼻剂
- 鼻凝胶
- 滴鼻剂
第六章 全球鼻腔给药装置市场，以容器形式，2019-2031 年（十亿美元）
- 介绍
- 加压容器
- 非加压容器
第七章 2019-2031 年全球鼻腔给药装置市场（按应用划分）（十亿美元）
- 介绍
- 慢性阻塞性肺病（COPD）
- 鼻炎
- 囊肿纤维化
- 鼻塞
- 气喘
- 其他的
第 8 章 全球鼻腔给药装置市场，依最终用户划分，2019-2031 年（十亿美元）
- 介绍
- 门诊手术中心
- 诊所
- 医院
- 其他的
第9章2019-2031年全球鼻腔给药装置市场（按地区）（十亿美元）
- 介绍
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
第10章竞争格局
- 公司简介
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- BF Ascher &Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
第十一章分析师建议
- 上升和下降
- 综合机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
Global intranasal drug delivery devices market is estimated to be valued at USD 1.70 Bn in 2024 and is expected to reach USD 3.27 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.70 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.80% | 2031 Value Projection: | US$ 3.27 Bn |
Global intranasal drug delivery devices market growth is driven by factor like advantages associated with intranasal drug delivery such as avoidance of first-pass hepatic metabolism, rapid drug absorption into systemic circulation, and direct nose-to-brain delivery. Intranasal drug delivery provides a non-invasive route for administering both local and systemic drugs. Rising product launches and substantial investments from players focused on developing advanced nasal spray and nebulizer technologies can drive the market growth.
Market Dynamics:
Global intranasal drug delivery devices market growth is driven by growing preference for alternate routes of drug delivery, rising incidence of chronic illnesses requiring long-term drug therapies, and technological advancements in nasal drug delivery devices. Non-invasive nature and rapid onset of action offered by intranasal delivery encourages various drug developers to explore this route. However, factors such as limitations on drug molecule size for intranasal absorption and risks of nasal irritation and congestion can hamper the market growth. Ongoing R&D focused on expanding the repertoire of applicable drug molecules and formulating safer nasal drug delivery technologies can offer market growth lucrative opportunities.
Key Features of the Study:
This report provides in-depth analysis of the global intranasal drug delivery devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global intranasal drug delivery devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include OptiNose, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global intranasal drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation-
- By Dosage Form
- Nasal Spray
- Nasal Drop
- Nasal Gel
- Nasal Powder
- By Container Type
- Pressurized Containers
- Non-pressurized Containers
- By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Rhinitis
- Cystic Fibrosis
- Nasal Congestion
- Asthma
- Others
- By End User
- Ambulatory Surgical Centres
- Clinics
- Hospitals
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Intranasal Drug Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Intranasal Drug Delivery Devices Market, By Dosage Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Nasal Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Drop
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Intranasal Drug Delivery Devices Market, By Container Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Non-pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Intranasal Drug Delivery Devices Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chronic Obstructive Pulmonary Disease (COPD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Congestion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Intranasal Drug Delivery Devices Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Intranasal Drug Delivery Devices Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- B.F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
- GlaxoSmithKline PLC
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
